Clinical Trials Browser

Phase 2 × Therapeutics × Thoracic × Clear all

NCT01929200 2015-05-22

Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01097317 2011-08-08

First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms